Midgard Science

Labs / Assays & in vitro testing

3C Therapeutics

Vancouver, BC, Canada · 3ctherapeutics.com

GMP

3C Therapeutics develops degrader-antibody conjugates for cancer, with an initial focus on aggressive solid tumors. It is based in Vancouver, British Columbia, Canada, and works on partnered scientific collaborations and investment discussions.

They take quote requests by email.

What they offer

  • Degrader-antibody conjugate development

    Develops DAC candidates by combining antibody-directed delivery with targeted protein degradation.

  • Targeted protein degradation platform development

    Builds a proprietary TriCore platform to expand targeted protein degradation to harder-to-reach cancer targets.

  • Ligand design collaboration

    Collaborates on hit-to-lead ligand design for DAC payloads and downstream candidate development.

  • DAC assembly and biological evaluation

    Assembling degrader-antibody conjugates and evaluating them biologically as part of lead selection.

What they work on

Modalities
Antibody, ADC, Peptide, Cell therapy
Assays and studies
target engagement, protein degradation, biological evaluation
Therapeutic areas
cancer, oncology, solid tumors
Sites
Vancouver, Canada
Address
pairing 3C’s TriCore DAC platform with Variational AI’s Enki™ generati

Similar labs. ORF Biologics, Sparx BIO, Aurigene Pharmaceutical Services, Esco Aster

Found in a contract services directory. Listing built from 3ctherapeutics.com. Work here? Claim this listing.

3C Therapeutics · Midgard Science